Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
768.500.22%
QQQ
719.680.1%
BTC/USD
78301.100.9978%
DIA
529.860.79%
GLD
403.240.87%
TLT
82.240.04%

TG Therapeutics Inc (TGTX) Stock Price, Quote, News & History

TGTXNASDAQ
Trade with Public
Trade with Public
$55.98
-0.73-1.28%
At close: Sep 3, 5:00 PM EST
$55.67
-1.04-1.83%
Pre-Market: 8:29 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

TG Therapeutics (TGTX) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
-
Close
$55.99
Volume / Avg.
11.12K / 2.43M
Day Range
- - -
52 Wk Range
26.76 - 59.30
Market Cap
$8.52B
P/E Ratio
20.43
Dividend Yield
-
Exchange
NASDAQ
RSI
57
Short Interest
28.43%
Days to Cover
12.59

Recent TG Therapeutics, Inc. News

MARA Holdings, Coinbase Global, Ternium And Other Big Stocks Moving Higher On Friday

Dow Jones index gained around 350 points on Friday. MARA Holdings Inc (NASDAQ: MARA) rose sharply, while Bitcoin (CRYPTO: BTC) also traded higher. Other stocks recording gains include Evolution Metals (NASDAQ: EMAT), TRON (NASDAQ: TRON), Bakkt (NYSE: BKKT), Rezolute (NASDAQ: RZLT), Gemini Space Station (NASDAQ: GEMI), Robinhood Markets (NASDAQ: HOOD), Strive (NASDAQ: ASST), Moderna (NASDAQ: MRNA), Coinbase Global (NASDAQ: COIN), Bitdeer Technologies (NASDAQ: BTDR), and Circle Internet Group (NYSE: CRCL).
Avi Kapoor

TG Therapeutics Stock Rises Thursday: What's Driving The Gains?

TG Therapeutics shares are trading higher on Thursday as traders keep leaning into recent upbeat clinical updates around BRIUMVI.
Henry Khederian

Top 3 Health Care Stocks That May Collapse This Quarter

3 health care stocks flashing warning: CAH RSI 77.7, TGTX RSI 79.8, AMRX RSI 76.9; all overbought, but positive price action for TGTX.
Avi Kapoor

TG Therapeutics Stock Is Surging Today: What's Driving The Action?

TG Therapeutics shares are trading higher on Wednesday as positive topline Phase 1 data fuels fresh optimism around pipeline expansion.
Henry Khederian

Caseys General Stores Upbeat Q4 Earnings, Joins Applied Optoelectronics, Clover Health Investments And Other Big Stocks Moving Higher On Wednesday

US stocks down, Dow Jones fell 150 pts on Wed. Caseys General Stores Inc (CASY) shares up 14.4% after beating earnings. Other big gainers incl. CBRL, PLBL, RXT, YB, AXTI, AAOI, LMND, CLOV, TGTX, CRDO, CBRS, HOOD, FLNC, LITE, TTMI
Avi Kapoor
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
17.88M
Investing Cash Flow (TTM)
21.89M
Financing Cash Flow (TTM)
313.73M
Free Cash Flow (TTM)
17.39M
Capital Expenditure (TTM)
-491.00K
Net Change in Cash (TTM)
353.50M

Analyst Trends and Forecast

2
May
3
1
Jul
1
Aug
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$8.77B
PE Ratio (TTM)
20.43
PE Ratio (FWD)
25.91
PEG Ratio (TTM)
-
PS Ratio (TTM)
11.17
PB Ratio (TTM)
14.19
Earnings Yield % (TTM)
4.89%
Earnings Yield % (FWD)
3.86%
EV / EBITDA (TTM)
62.93
Price / EBITDA (TTM)
64.06
Price / Free Cash Flow (TTM)
513.62
Book Value / Share
$3.95

Company Debt

Total Debt
$745.39M
LT Debt
$745.39M
LT Debt Issuance (TTM)
$747.66M
LT Debt Repayment (TTM)
-$255.00M
Total Cash
$482.58M
Debt to Equity
1.25
Issuance of Debt (TTM)
$492.66M
Repayment of Debt (TTM)
-$255.00M

Key Statistics

Open
-
Close
$55.99
Volume / Avg.
11.12K / 2.43M
Day Range
- - -
52 Wk Range
26.76 - 59.30
Market Cap
$8.52B
P/E Ratio
20.43
Dividend Yield
-
Exchange
NASDAQ
RSI
57
Short Interest
28.43%
Days to Cover
12.59

About

Sector
Health Care
Industry
Biotechnology
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval fr...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy TG Therapeutics (TGTX) stock?

A

You can purchase shares of TG Therapeutics (NASDAQ:TGTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are TG Therapeutics (TGTX) competitors?

Q

What is the forecast, or price target, for TG Therapeutics (TGTX) stock?

A

TG Therapeutics has a consensus price target of $51.45.

Q

What is the current price for TG Therapeutics (TGTX)?

A

The stock price for TG Therapeutics (NASDAQ: TGTX) is $55.6719 last updated September 8, 2026 at 8:06 AM EDT.

Q

Does TG Therapeutics (TGTX) pay a dividend?

A

There are no upcoming dividends for TG Therapeutics.

Q

When is TG Therapeutics (NASDAQ:TGTX) reporting earnings?

A

TG Therapeutics does not have any upcoming earnings scheduled.

Q

Is TG Therapeutics (TGTX) going to split?

A

There is no upcoming split for TG Therapeutics.

Q

What sector and industry does TG Therapeutics (TGTX) operate in?

A

TG Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved